Explore the words cloud of the Pharma-Factory project. It provides you a very rough idea of what is the project "Pharma-Factory" about.
The following table provides information about the project.
ST GEORGE'S HOSPITAL MEDICAL SCHOOL
|Coordinator Country||United Kingdom [UK]|
|Total cost||9˙254˙335 €|
|EC max contribution||8˙286˙008 € (90%)|
1. H2020-EU.22.214.171.124. (Developing integrated biorefineries)
|Duration (year-month-day)||from 2017-11-01 to 2021-10-31|
Take a look of project's partnership.
|1||ST GEORGE'S HOSPITAL MEDICAL SCHOOL||UK (LONDON)||coordinator||1˙715˙885.00|
|2||FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.||DE (MUNCHEN)||participant||624˙547.00|
|3||Teknologian tutkimuskeskus VTT Oy||FI (Espoo)||participant||560˙827.00|
|4||UNIVERSITE DE ROUEN NORMANDIE||FR (MONT SAINT AIGNAN CEDEX)||participant||531˙500.00|
|5||UNIVERSITY COLLEGE LONDON||UK (LONDON)||participant||524˙226.00|
|6||THE UNIVERSITY OF THE ARTS LONDON||UK (LONDON)||participant||520˙000.00|
|7||UNIVERSIDAD DE LLEIDA||ES (LLEIDA)||participant||519˙902.00|
|8||TRANSALGAE ISRAEL LTD||IL (TEHOVOT)||participant||519˙750.00|
|9||AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS||ES (MADRID)||participant||519˙710.00|
|10||JOHN INNES CENTRE||UK (NORWICH)||participant||509˙982.00|
|11||DIAMANTE SRL||IT (VERONA)||participant||499˙625.00|
|13||ALBAJUNA THERAPEUTICS||ES (BADALONA)||participant||400˙312.00|
|14||LEAF SYSTEMS INTERNATIONAL LIMITED||UK (NORWICH)||participant||384˙040.00|
Plant Molecular Farming is the manufacture of high-value products using plant biotechnology. Pharma-Factory was conceived and designed by SMEs active in the field to produce medical, veterinary and diagnostic products. Product-driven work packages and a collective approach to public involvement and regulatory consultation will accelerate commercialisation of new bio-products, and increase the competitiveness of European bio-industry by resolving technical, social and economic bottlenecks in this field. All parts of the work programme are addressed by refining technologies using new synthetic biology tools, demonstrating manufacturing advantages for individual products, identifying a clear regulatory path for each platform technology, developing clear business cases with supporting techno-economic evaluations and life cycle analyses and improving public engagement and acceptance. Five SMEs will develop products that include arylsulfatase B (for human enzyme replacement therapy), a vaccine for infectious spleen and kidney necrosis virus in fish, two highly potent HIV neutralising antibody-based fusion proteins and plant chimaeric virus-like-particles for a diagnostic kit. In collaboration with academic partners they will advance six plant molecular farming platforms for this purpose, including whole plants, algae, hairy roots and plant cell culture, by designing and developing new tools to increase the competitiveness, utility and versatility of each platform. All companies will reach Technology Readiness Level 5 within the lifetime of the project, with two products to be commercialized. The project provides a unique opportunity to improve public involvement with plant biotechnology at a European-wide level. A work package has been dedicated to gain maximal impact by engaging with all stakeholders – from scientists to government and the public at large, developing new tools to facilitate communication, to help understand and reduce barriers to acceptance.
|Project website||Websites, patent fillings, videos etc.||2019-11-25 11:41:00|
Take a look to the deliverables list in detail: detailed list of Pharma-Factory deliverables.
|year||authors and title||journal||last update|
Evangelia Vamvaka, Gemma FarrÃ©, Luis M. Molinos-Albert, Abbey Evans, Anna Canela-Xandri, Richard M. Twyman, Jorge Carrillo, Raziel A. OrdÃ³Ã±ez, Robin J. Shattock, Barry R. Oâ€™Keefe, Bonaventura Clotet, Julian Blanco, Gurdev S. Khush, Paul Christou, Teresa Capell
Unexpected synergistic HIV neutralization by a triple microbicide produced in rice endosperm
published pages: E7854-E7862, ISSN: 0027-8424, DOI: 10.1073/pnas.1806022115
|Proceedings of the National Academy of Sciences 115/33||2019-11-25|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PHARMA-FACTORY" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PHARMA-FACTORY" are provided by the European Opendata Portal: CORDIS opendata.